Research Focus Areas
CIBMTR has collected health outcomes data worldwide for 50+ years, resulting in an Outcomes Database with information from 700,000+ patients. At any given time, CIBMTR has 185+ ongoing studies and clinical trials:
Working Committees
CIBMTR’s Working Committees oversee most of CIBMTR’s observational research. Each committee focuses on a specific disease, use of cellular therapy, or complication of therapy. Anyone willing to take an active role in developing and completing studies may join a Working Committee.
Clinical Trials
CIBMTR Clinical Research Organization (CRO) Services conducts trials of all phases with specific expertise in Phase I and Phase II trials.
CIBMTR also supports the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), which conducts multicenter Phase II and III trials with broad national participation.
Patient-Centered Outcomes and Implementation Science
CIBMTR improves cellular therapy outcomes by collecting, sharing, and researching patient-reported outcomes, and implementation science systematically closes the gap between research and practice.
Immunobiology Research
CIBMTR manages a repository of tissue samples from donors and recipients, both unrelated and related, to study the genetic, cellular, and immunologic factors that influence transplant outcomes.
Statistical Methodology Research
CIBMTR Biostatisticians provide advice and statistical consultation to researchers developing protocols for cellular therapy studies, and they investigate new statistical approaches and techniques for analyzing cellular therapy data.
Bioinformatics Research
CIBMTR develops and utilizes software tools and analytic methods to discover new patterns and biomarkers, predict clinical outcomes, facilitate cellular therapy matching, and model inventory sources to save and improve patient lives.